Next, we explored whether other microglial markers, such as the microglia-associated triggering receptor expressed on myeloid cells (TREM2) and CD68, that may be altered in the presence of amyloid pathology, were affected by DHA treatment. The gene discussed is TREM2; the disease is amyloidosis.